Vascular Solutions says the FDA granted 510(k) clearance for its Gel-Block embolization foam.
A Covidien study has shown that its new VenaSeal system is just as effective in treating chronic leg vein disorders as its ClosureFast ablation catheter.
The U.S. Justice Dept. issues a 9-count indictment charging Vascular Solutions and CEO Howard Root with running an off-label promotion scheme for its Vari-Lase laser varicose vein device.
Manufacturers of inferior vena cava filters and 2 medical societies team up for a large-scale study of the pulmonary embolism preventers, 4 years after an FDA warning about the devices.
The Society of Interventional Radiology, the Society for Vascular Surgery and 7 medical device companies are teaming up for the 1st large-scale study of inferior vena cava filters, 4 years after an FDA warning that the devices might dislodge or fracture.
Abbott Vascular reportedly lays off 100 workers at a plant in Temecula, Calif.
Abbott Vascular (NYSE:ABT) is laying off about 100 workers at a California plant it acquired when it bought a portion of Guidant Corp. in 2006.
The Clearstream Technologies subsidiary acquired 3 years ago by C.R. Bard is reportedly expanding in Ireland, adding 200 jobs at its Enniscorthy plant.
Vascular Dynamics reports raising $10 million out of a hoped-for $23 million funding round for its MobiusHD anti-hypertension implant.
Vascular Dynamics said it raised nearly $10 million from a group of unnamed investors for the hypertension implant it's developing.
The Mountain View, Calif.-based startup reported raising $9.7 million in an offering of stock, warrants and other securities as part of a proposed $22.9 million funding round.